Scottsdale is a clinical research site located in Scottsdale, Arizona, United States 85054.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Scottsdale has participated in 8 clinical trials with 2 currently active.
Therapeutic areas: Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Diabetic Macular Edema (DME).
Sponsors: Finch Research and Development LLC., Corcept Therapeutics, EyeBiotech Ltd..
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Scottsdale has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Scottsdale has 8 clinical trials on record, with 2 currently active. Their work covers Clostridium Difficile Infection Recurrence, Metastatic Castration-Resistant Prostate Cancer, Diabetic Macular Edema (DME).
Yes — Scottsdale holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.